Oral Ketamine for Depression
The Journal of Clinical Psychiatry April 15, 2019 Joshua D. Rosenblat, André F. Carvalho, Madeline Li et al. 111 citations
OBJECTIVE: Intravenous (IV) ketamine has rapid and robust antidepressant effects; however, poor accessibility of the IV route often limits its use. Numerous alternative routes of administration are being investigated. Oral ketamine is particularly appealing for its ease of use with the potential for high accessibility. The objective of the current systematic review, in accordance with PRISMA,...
DOI: 10.4088/jcp.18r12475 (opens in new tab)
Ketamine
Depression economics